Assignee
THIOGENESIS THERAPEUTICS INC
US·4 granted patents·1 pending application·5 citations·filing 2017–2023
Top patents by PatentIndex Score
5 records- 0188US11173135B2Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disordersTHIOGENESIS THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·4 cites·18 claims
- 0276US12569456B2Methods for the treatment of cysteamine sensitive disordersTHIOGENESIS THERAPEUTICS INC·Filed 2023·Granted Mar 10, 2026·0 cites·20 claims
- 0372US11612576B2Methods for the treatment of cysteamine sensitive disordersTHIOGENESIS THERAPEUTICS INC·Filed 2018·Granted Mar 28, 2023·1 cites·8 claims
- 0465US11786491B2Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disordersTHIOGENESIS THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·20 claims
- 0546US2023218571A1Cysteamine precursor compounds for the treatment of betacoronavirus infectionsTHIOGENESIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THIOGENESIS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →